Concepedia

Publication | Open Access

108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)

12

Citations

0

References

2022

Year

No additional data available for this publication yet. Check back later!